EpiShuttle launched to fight monkeypox
The Hellenic Air Force’s C-130 Hercules landed at Kefalonia airport to pick up two British tourists diagnosed with symptoms reminiscent of monkeypox, using EpiShuttle
In general, EpiShuttle will provide protection from all biohazards, bacteria, and viruses. The standard A2P3 filter will in addition to particles also filter organic gases and vapors with a boiling point above 65°C. This covers most of the warfare agents.
Not all hospitals are equipped to handle such contagious diseases, therefore intra hospital transfer is crucial. Also, when handling any epidemic outbreak, intra hospital transfer is prominent to handle a surge of patients in an area with limited intensive care capacity.
Ellen Cathrine Andersen, CEO of EpiGuard, the Norwegian company producing EpiShuttles, said: “The EpiShuttle is completely airtight, and as a second barrier it has negative pressure with P3-filtration to prevent any contaminated air from escaping the isolator. The EpiShuttle keeps the staff safe. Also, once the patient is loaded, medical staff do not have to wear full Personal Protective Equipment during transport of highly infectious patients.”
The EpiShuttle is NATO stock listed and CE-marked as a class one medical device. EpiShuttles are used by WHO as well as first responders in Germany, Belgium, Denmark, Peru, Ireland, Greece, Norway, and the UK. Also, national air forces like the British, Australian, Canadian, Danish, Norwegian and others are equipped with EpiShuttles.